more

Related Articles

BlackRock to Buy Real Estate Firm MGPA for Asia, Europe Push
Clearlake Buys Equipment Unit for $244M
Centerfield Capital Closes $171M Fund
Vista Equity Takes Websense Private for $1B
Clarion Partners, Madison Street Capital, NBGI Private Equity

SLIDESHOW

The M&A Scene: CEO Leadership
Dealmakers gathered at the Harvard Club in New York on May 7 as part of ACG NY's CEO Leadership event. Peter Gonye, a co-leader within Spencer Stuart's private equity practice in North America was the keynote speaker. Panelists included M. Tatum Pursell, senior adviser, Unlimited Horizons; Tony Ecock, general partner, Welsh Carson Anderson & Stowe; Jim Follett, former CEO of Authentic Response Inc.; Doron Grosman, operating partner, Court Square Capital; and Joelle Marquis, partner, Arsenal Capital.

Watercooler

10 Startups Marissa Mayer Bought Before Tumblr
Summly, a news-sharing service Yahoo picked up in March for $30 million, tops the list of purchases the new CEO made before the $1.1B deal for Tumblr

Dealmakers

3Qs With…Chris Randall, executive vice president, NBH Capital Finance
NBH Capital Finance will focus on the lower middle market

Columns

Remark Media Refocuses on Young Adults
Remark has operated at a loss since inception but is now focusing on growing its personal finance group, as well as media properties

Today's Transactions:
TPG Backs Team to Take ShangPharma Private

The deal is being facilitated through the San Francisco firm's life science unit TPG Biotech

By ANTHONY NOTO
December 21, 2012

Private equity firm TPG Capital backed a consortium of buyers as part of a deal that would see ShangPharma Corp. (NYSE: SHP) be taken private for $173 million.

Through its life science venture investment arm TPG Biotech, the San Francisco firm has teamed with ChemExplorer Investment Holdings Ltd., ChemPartner Investment Holdings Ltd., Joint Benefit Group Ltd. and Han Ming Tech Investment Ltd. to purchase ShangPharma for 50 cents per share.

The offer represents a 30.8 percent premium over the closing price of $6.88 per share on July 5, the last trading day prior to the Shanghai company's announcement that it had received a "going private" proposal.

Investment adviser J.P. Morgan Securities (Asia Pacific) Ltd. managed the assignment, while O'Melveny and Myers LLP and Ropes & Gray LLP served as U.S. legal advisers.

Skadden Arps Slate Meagher & Flom LLP handled legal matters for the target.

 

For more information on related topics, visit the following: